Credit Rating Affirmation
Neuland Laboratories Credit Ratings Affirmed by India Ratings
NSE
NEULANDLAB
BSE
524558
Neuland Laboratories Limited announced that India Ratings and Research (Ind-Ra) has affirmed the company’s credit ratings for its bank loan facilities. The long-term rating remains at IND A+ with a Positive Outlook, while the short-term rating continues at IND A1, reflecting the agency’s continued assessment of the company’s credit profile.
PRICE-SENSITIVE TRIGGER
Event: India Ratings & Research affirmed the company’s credit ratings for bank loan facilities.
Type: Credit Rating Affirmation
Impact: Positive
Immediate Effect:Â The reaffirmation indicates continued confidence in Neuland Laboratories’ credit quality and financial profile, supporting the company’s access to bank financing on existing credit terms.
Financials:
Key Metrics:
- Facility: Bank Loan Facilities
- Long-Term Rating: IND A+
- Outlook: Positive
- Short-Term Rating: IND A1
- Rating Action: Affirmed
Highlight:
- India Ratings reaffirmed Neuland Laboratories’ long-term rating at IND A+/Positive and short-term rating at IND A1.
What Happened ?
Neuland Laboratories informed the stock exchanges that India Ratings and Research has reaffirmed the credit ratings assigned to the company’s bank loan facilities.
The reaffirmation covers both the long-term and short-term ratings, with no change in the existing rating levels or outlook.
key details
Credit Rating Action:
- Rating agency: India Ratings and Research (Ind-Ra).
- Long-term bank loan rating affirmed at IND A+.
- Outlook remains Positive.
- Short-term bank loan rating affirmed at IND A1.
- Rating action: Affirmed.
Business Significance:
- Reflects continued assessment of the company’s creditworthiness.
- Positive outlook indicates expectations of sustained business and financial performance.
- Supports confidence among lenders and other financial stakeholders.
- Reinforces the company’s financing profile for bank borrowings.
Note:
- The affirmation maintains the company’s existing credit standing rather than introducing a revised rating.
Risk Analysis
Summary:
- The rating affirmation is credit positive; however, future rating actions will depend on the company’s operating performance, profitability, leverage and cash flow generation.
Key Risks:
- Any deterioration in financial performance could affect future rating reviews.
- Changes in leverage or liquidity metrics may influence subsequent rating actions.
- Business or industry challenges could impact the current Positive Outlook.
Worst Case:
- If operating performance weakens materially, the rating outlook or rating itself could be revised in future periodic reviews.
Risk Level: Low
Company Commentary
- India Ratings and Research has affirmed the ratings assigned to its bank loan facilities.
- The long-term rating remains IND A+ with a Positive Outlook.
- The short-term rating continues at IND A1.
- The disclosure was made under Regulation 30 of the SEBI (LODR) Regulations, 2015.
Official Exchange Filing: Neuland Laboratories Limited
